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ABSTRACT 
The balance between the immune/inflammatory and regenerative responses in the diseased pulp is 
central to clinical outcome and this response is unique within the body due to its tissue site. 
Cariogenic bacteria invade the dentin and pulp tissues triggering molecular and cellular events 
dependent on the disease stage. At the early onset, odontoblasts respond to bacterial components in 
an attempt to protect the tooth’s hard and soft tissues and limit disease progression. However as 
disease advances the odontoblasts die and cells central to the pulp core, including resident immune 
cells, pulpal fibroblasts, endothelial cells and stem cells, respond to the bacterial challenge  via their 
expression of a range of pattern recognition receptors which identify pathogen associated molecular 
patterns. Subsequently there is recruitment and activation of a range of immune cell types, including 
neutrophils, macrophages, T- and B-cells, which are attracted to the diseased site by 
cytokine/chemokine chemotactic gradients initially generated by resident pulpal cells. While these 
cells aim to disinfect the tooth, their extravasation, migration and antibacterial activity [e.g. release 
of reactive oxygen species (ROS)] along with the bacterial toxins cause pulp damage and impede 
tissue regeneration processes. Recently, a novel bacterial killing mechanism termed Neutrophil 
Extracellular Traps (NETs) has been described which utilizes ROS signaling and results in cellular DNA 
extrusion. The NETs are decorated with antimicrobial peptides (AMPs) and their interaction with 
bacteria results in microbial entrapment and death. Recent data demonstrate that NETs can be 
stimulated by bacteria associated with endodontic infections and they may be present in inflamed 
pulp tissue. Interestingly some bacteria associated with pulpal infections express DNase enzymes 
which may enable their evasion of NETs. Furthermore, while NETs aim to localize and kill invading 
bacteria using AMPs and histones, limiting the spread of the infection, data also indicate that NETs 
can exacerbate inflammation and that their components are cytotoxic. This review considers the 
potential role of NETs within pulpal infections and how these structures may influence the pulp’s 
vitality and regenerative responses.   
INTRODUCTION 
Previously we have described how the pulp’s response to infection and injury is similar to that of 
many other tissues in the body [1]. Cells of the dentin-pulp complex detect invading bacteria by their 
expression of a range of pattern recognition receptors (PRRs), which identify pathogen associated 
molecular patterns (PAMPs). The PRRs reported as being present in the pulp include Toll-like receptors 
(TLRs), Nucleotide-binding oligomerization domain (NOD) -1 and -2 proteins and the Nod-like receptor 
(NLR) family member pyrin domain containing 3 (NLRP3) complex, also known as the inflammasome. 
The expression of many of these molecules has been shown on odontoblasts, pulp fibroblasts, pulp 
stem cells, neurones and endothelial cells, and they are able to detect several components of the 
invading bacteria ranging from their DNA to outer membrane components, such as lipopolysaccharides 
(LPSs) [2-12]. Once host cells have detected bacterial components, they induce the expression of 
antimicrobial peptides (AMPs) as well as invoking the inflammatory cascade with both processes aimed 
at containing, and ultimately eradicating, the infection [13-15]. Initially, due to their location at the 
periphery of the pulp, it is the odontoblasts [16] that are the first responders; however, as the infection 
advances, cells deeper in the pulp core, including pulp fibroblasts, endothelial cells and stem cells, also 
become involved in the defense reaction [4,5]. In addition there are immune cells resident in healthy 
pulp tissue, such as dendritic cells and mast cells, that act as sentinels and also orchestrate the early 
local immune response [17-21]. 
 At the molecular level, detection of bacterial components via the PRRs results in the activation of 
intracellular signaling cascades, with the primary effects being mediated via the NF-κB and p38-MAP-
kinase proteins [6,7,22,23]. These pathways ultimately culminate in the translocation of master 
regulatory transcription factors, such as AP-1, STAT1 and NF-κB, from the cytoplasm to the nucleus 
where they activate the gene expression of pro-inflammatory cytokines and chemokines such as 
interleukin-1, -1 (IL1-, -), tumor necrosis factor-α (TNF-α), IL-4, IL-6, IL-8 and IL-10. Notably, this 
pool of inflammatory mediators can be added to by the cytokines released by bacterial acids during the 
carious disease process [13-15,24,25]. Subsequently, these molecules induce both autocrine and 
paracrine effects which amplify the inflammatory and immune responses, and in particular generate 
chemotactic gradients which lead to the recruitment of immune cells from the vasculature, including T- 
and B-lymphocytes, plasma cells, neutrophils, monocytes and macrophages [17-19]. Notably, the 
extravasation, migration and antimicrobial defense responses of these immune cells can lead to 
significant collateral tissue damage. This response combined with the increasing infection, significantly 
affects the vitality of the pulp tissue and results in extracellular matrix (ECM) breakdown and death of 
resident cells.  
 During early stages of disease or when the infection has been minimized, either by the host’s 
immune response or by clinical intervention, the tooth tissue may evoke tertiary dentinogenic 
responses. As has been described in detail elsewhere [26], these responses can be relatively simple in 
the form of reactionary dentinogenesis, which involves the direct activation of the existing primary 
odontoblasts, or the response may be relatively more complex in the case of reparative 
dentinogenesis, which involves orchestrated stem cell responses culminating in the generation of new 
odontoblast-like cells. We have also previously reviewed and described the links between the 
inflammatory and the tertiary dentinogenic responses as there is clear crosstalk between the two 
processes [26-28]. Indeed, it appears evident that many molecules that signal the inflammatory 
response, such as bacterial components, cytokines, complement and reactive oxygen species (ROS), 
can also stimulate aspects of tertiary dentinogenic responses [29-35]. Furthermore, signaling pathways, 
such as the p38-MAP-kinase cascade, are also activated during both processes [36]. Subsequently it 
appears likely that the activity of the intracellular signaling cascades and associated cell responses are 
dose and context specific. Potentially, the relatively low doses of stimuli, present during the early or 
resolving stages of disease stimulate regenerative responses, while more intense stimuli, which occur 
during active and chronic disease, inhibit regeneration. Interestingly, during incipient disease, when 
inflammatory levels are likely relatively low, repair responses elicited may also serve in generating a 
physical barrier of dental hard tissue which “walls off” the invading bacteria. The dosage effects and 
responses discussed above would appear to be somewhat intuitive as it would not be appropriate and 
potentially result in a waste of cellular resource to attempt to rebuild the damaged tissue while the 
infection and immune responses are both raging. Notably, the clotting and haemostatic responses will 
also ensue within the dentin-pulp complex to limit blood loss and provide a scaffold for later tissue 
repair. Interestingly, knowledge of this process is being exploited for the development of new scaffold 
materials that provide a framework to stimulate stem cell-based repair responses [37,38]. 
Innate immune response to dental tissue infection 
Up to 700 bacterial species have been reported in the oral cavity with individuals harboring up to 200 
different species per individual [39]. High-throughput nucleic acid sequencing approaches have shown 
that endodontic infections are highly complex and diverse and can contain well over 100 bacterial 
genera from several different phyla [40-43]. Their polymicrobial nature is dominated by Gram negative 
obligate anaerobic bacteria which form complex biofilms extending into dentinal tubules and the root 
canal network. Notably, likely due to environmental similarities, e.g. anaerobic and nutrient availability, 
many of the bacteria present in deep endodontic infections are also present in periodontal infections 
[39]. The composition and distribution of this biofilm within the tooth’s root system make it clinically 
challenging to eliminate all invading microorganisms [44]. As described above, the dental tissue mounts 
its own innate immune response which aims to eradicate the infection and restore inflammatory levels 
to those conducive for tissue repair (Figure 1). Similar to wound infection occurring at other sites in the 
human body, it is neutrophils [polymorphonuclear leukocytes (PMNs)] that are abundantly recruited 
and provide the first line of defense in the innate immune response in the pulpal tissue [21,45,46]. 
Neutrophils initially mature in the bone marrow, and it is estimated that even during health ~1-2 x1011 
cells are generated per day [47].  Due to their role and the increased demand placed upon the immune 
system during infection, their levels released into the bloodstream increase, the cells also become 
primed and their longevity increases [48].  When circulating and surveying for microorganisms, 
neutrophils reportedly have an average lifespan of ~5.4 days, following which point they subsequently 
undergo apoptosis and are removed by macrophages [49].  Their priming, prior to reaching the site of 
infection, is important as it aids their rapid response for pathogen clearance. This peripheral priming is 
achieved by activation by various cytokines, growth factors, complement or bacterial components. As 
described above, during infection a chemotactic gradient within the diseased pulp is generated by 
cytokines, such as IL-8, complement components and bacterial peptides (f-Met-Leu-Phe), which 
instruct the neutrophil to leave the circulation and traverse to the site of infection. The process of 
neutrophil recruitment involves the steps of tethering, rolling, adhesion, crawling and, finally, 
transmigration. The process is initiated by changes on the surface of the vascular endothelium and this 
is mediated by pro-inflammatory mediators released from tissue resident cells or by PAMPs. Notably, 
while neutrophils aim to combat the invading bacteria, it is known that they can also be one of the 
most significant mediators of local host tissue damage due to their release of ROS and proteolytic 
enzymes as they traverse the tissue to the site of infection [50]. 
Neutrophil antibacterial mechanisms  
Once at the site of infection, neutrophils can utilize an antimicrobial armamentarium that exploits both 
intra- and extracellular killing mechanisms (Figure 2) and they have at their disposal significant 
antimicrobial proteins and molecules. Following contact with bacteria, the neutrophil can undertake 
phagocytosis and encapsulation into phagosomes. The neutrophil then destroys the pathogens by 
intracellular release of ROS (via NADPH oxygenase-dependent mechanisms) or AMPs, such as 
cathepsins, defensins, lactoferrin and lysozyme. Notably, these AMPs are not only released by the 
neutrophil granules into phagosomes but also into the extracellular milieu. Hence, degranulation can 
provide an extracellular killing mechanism however it may also cause further host collateral tissue 
damage [51-53].  
Human neutrophils consecutively form three types of granules, packed with pro-AMPs and 
inflammatory proteins, during their cellular maturation. Azurophilic (or primary) granules, contain 
myeloperoxidase (MPO and azurocidin), specific (secondary) granules, contain lactoferrin, and 
gelatinase (tertiary) granules, contain matrix metalloproteinase 9 (MMP9; also known as gelatinase B). 
Notably, azurophilic granules can be further subdivided depending on peroxidase and defensin content. 
Specific granules can also be further subdivided based on lactoferrin, cysteine-rich secretory protein 3 
(CRISP3), gelatinase and ficolin content. Multiple types of neutrophil granules are generated as many of 
the proteins described cannot exist together in the innate form due to proteolytic interactions [54].  
 
Neutrophil Extracellular Traps 
NET Biology 
In 2004, a novel extracellular mode of neutrophil-mediated pathogen containment and killing was 
described which was termed neutrophil extracellular traps (NETs) [55]. NETs are web-like structures 
containing de-condensed nuclear chromatin adorned with antimicrobial molecules, including histones 
and the AMPs derived from azurophilic specific and gelatinase granules [55]. Proteins demonstrated as 
being associated with NETs include i) AMPs, such as lactoferrin, cathepsin G, defensins, LL37 and 
bacterial permeability increasing protein, ii) proteases, such as neutrophil elastase, proteinase 3 (PR3) 
and gelatinase, and iii) enzymes responsible for ROS generation, such as myeloperoxidase (MPO) [56-
59]. The electrostatic charge interactions between the core DNA and bacterial outer membrane/wall is 
understood to enable the interaction with bacteria. This ‘stickiness’ extends over areas of several 
microns due to the structure of the NETs and enables entrapment of bacteria moving within the tissue 
microenvironment and subsequently facilitates the co-localisation of high concentrations of 
antimicrobial molecules [60]. 
NETs are only released by mature neutrophils and their formation is impaired in neonates, which 
may predispose them to infection [61]. It is also evident that multiple signaling receptors (e.g. for 
bacterial components, cytokines/chemokines and complement) need to be triggered for NET release 
(see below). This indicates the need to tightly regulate this process as it likely represents a ‘last resort’ 
in neutrophil killing. Indeed, this process represents a form of programmed cell death which is termed 
NETosis and is distinct from apoptosis and necrosis [62]. Notably, however in 2009, Yousefi and 
colleagues demonstrated that the expulsion of mitochondrial NETs (as opposed to nuclear DNA-NETs) 
provides a means for cells to remain viable.  The mitochondrial NET release process arguably requires 
less potent stimulation, potentially providing a relatively rapid anti-microbial strategy, which 
complements other neutrophil killing mechanisms [63]. 
 
 
Signaling of NET release 
ROS release represents an important antimicrobial strategy deployed by neutrophils. Interestingly, 
the generation of ROS underpins the signaling for NET production, indicating the association between 
these two antimicrobial strategies. As described in detail elsewhere [64], the ROS signaling pathway 
which utilizes nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase assembly, superoxide 
and hydrogen peroxide production, and subsequent conversion to hypochlorous acid (HOCl) by MPO, is 
necessary for NET release [65]. The importance of ROS signaling in regulating NET release is further 
highlighted in chronic granulomatous disease (CGD). Previously, only patients’ lack of ROS production 
was thought to be responsible for susceptibility to infection; however, more recently, their impaired 
NET production has also been shown implicated in their impaired infection control [66].  
The next relatively well characterised step in the regulation of NET production is the de-condensing 
of the nuclear chromatin which is achieved by enzymatic action. Knock-out mice for the calcium-
dependent enzyme, Peptidyl arginine deiminase-4 (PAD4), cannot make NETs under normal 
physiological conditions indicating the essential activity of this enzyme [67]. This citrullination process 
transforms positively charged arginine residues in histones to neutrally charged citrulline, leading to 
the loss of electrostatic attraction between the DNA and its packaging proteins [68]. Additionally, 
another mechanism for NET formation has also been described whereby primary granule-derived 
neutrophil elastase enters the nucleus and partially degrades histones enabling subsequent binding of 
MPO derived from the same granules, resulting in decondensation of the chromatin [69]. These series 
of events are also proposed to be triggered by ROS generation and both processes lead to chromatin 
de-condensation proceeding to nuclear morphological changes, nuclear membrane breakdown and 
associate with the neutrophil granules releasing their cargos. Subsequently, the DNA and antimicrobial 
proteins and enzymes combine with the chromatin in the cytoplasm prior to the rupturing of the 
neutrophil outer cell membrane and expulsion of these constructs [56]. Notably, the demonstration of 
MPO and/or neutrophil elastase co-located with DNA is important in identifying the presence of NET 
structures within tissues [55]. 
NET Stimuli 
The stimuli for NETs are complex and varied. Furthermore, the temporality and context of NET 
induction and release is crucial as aberrant release can impede other immune functions, such as 
chemotaxis and phagocytosis, as well as leading to downstream pathogenic events. Currently a range 
of disease relevant stimuli for NET production have been reported and include nitric oxide, cytokines, 
bacteria and their components, such as LPS and bacterial toxins, yeasts, fungi, protozoa, AMPs, 
antibodies, activated platelets and statins (reviewed in detail in [64]). Whilst not necessarily having 
physiological relevance, many in vitro studies utilize phorbol 12-myristate 13-acetate (PMA) as a 
stimulus for NETs (Figure 3). PMA works efficiently and directly, by bypassing receptor–ligand binding 
on the neutrophil surface, and activates cytoplasmic protein kinase C signaling which leads to 
intracellular ROS generation, which stimulates approximately one third of neutrophils to release NETs 
by 4-hours [60,62].   
Gram-positive and Gram-negative bacteria stimulate NET release [55] and their components, such 
as LPS, can either directly induce NETs or can indirectly cause NET release via platelet activation [70].  
Data from our group has shown that several bacteria and their components associated with endodontic 
infections are able to directly stimulate significant NET release in vitro albeit at levels considerably 
lower than those observed following PMA stimulation (Figure 3; & [71]). Many of the host-derived pro-
inflammatory mediators previously described as playing a role in pulpal inflammation, including TNFα, 
IL-1β and IL-8, have also been reported to induce NET formation [72].  Furthermore, the AMP, LL-
37/cathelicidin, previously reported as being involved in pulpal disease, can directly induce NET 
production as well as increasing NET release in response to bacteria [59].   
Microbial evasion of NETs 
The ionic interactions between the bacteria and NET-DNA is understood to cause microbes to become 
ensnared and preliminary data from our group have shown that bacteria present in endodontic 
infections are also susceptible to this entrapment (Figure 3; & [73]). However, as would be predicted 
by the host–pathogen co-evolutionary arms race, bacteria have subsequently developed virulence 
traits, which facilitate NET evasion. DNase enzymes expressed by bacteria have now been shown to 
confer resistance to this antimicrobial strategy. Indeed, studies in mice using Streptococcus 
pneumoniae demonstrated that the strain expressing the wild-type EndA DNase exhibited 20% 
increased resistance compared with the EndA deletion mutant. The wild-type strain also demonstrated 
an increased spread of infection into the lungs and bloodstream compared with the EndA deletion 
mutant strain [74]. Others have examined the role of DNase expression in NET evasion in group A 
streptococci. Notably, DNase deletion mutants in this strain of bacteria exhibited increased 
susceptibility to neutrophil killing in vitro, and in vivo they demonstrated significantly less virulence in 
causing necrotizing fasciitis compared with the wild-type strain [75]. These data indicate the 
importance of NETs in limiting bacterial invasion and dissemination. Another form of NET killing 
avoidance utilized by bacteria is their expression of a polysaccharide capsule a feature often 
associated with increased virulence. This bacterial outer covering modification has been shown to 
significantly decrease pneumococci entrapment by NETs compared with the non-encapsulated strains 
[76]. Cell wall lipoteichoic acid modification on Gram-positive bacteria is a further adaptation, which 
enables evasion of NET killing.  Some microorganisms appear to have evolved a relatively simple 
avoidance method and stimulate release of relatively few NETs. Interestingly, our analysis of a panel of 
dental bacteria has shown that several strains may utilize this strategy of modulating NET release [71]. 
 As early as 1974, Porschen & Sonntag reported DNAse activity in the endodontic infection-
associated Gram negative bacteria Fusobacterium nucleatum, however, at the time the purpose of this 
enzymatic activity was not known [77]. Subsequently, others and we have shown the expression of 
DNase in several dental-disease relevant Gram-negative bacteria in vitro [78,79]. Notably, the 
expression of these bacterial DNases was found to be culture condition dependent, i.e. it could occur 
during either planktonic or solid state growth, and activity was either secreted or membrane bound. 
Studies also demonstrated that this bacterial DNase was able to degrade NETs in vitro. Clearly, within a 
biofilm, such as that occurring within root canals, expression by certain bacteria at particular stages of 
growth may confer benefits to the whole microbial community in terms of NET killing evasion. This 
virulence trait of the biofilm as a whole may then enable further propagation and dissemination of 
bacteria within the endodontic tissues. Interestingly, bacterial DNase expression may also be important 
in modifying the biofilm matrix to enable plaque development and maturation [80].  
Endodontic disease associated bacteria may utilize several strategies to avoid NET entrapment, 
including DNase expression and modulated NET induction. In addition, bacteria such as Enterococcus 
faecalis, Porphyromonas gingivalis and Porphyromonas intermedia, have been shown to exhibit surface 
modifications including the presence of polysaccharide capsules with this phenotype strongly 
associating with root canal biofilm infections [81-83]. Whilst studies have not specifically correlated 
these bacterial outer surface modifications with NET evasion, there exists the potential that bacteria 
present in endodontic infections have evolved this type of virulence strategy to evade this form of 
innate immunity entrapment. 
 
Host response to NETs 
Whilst the NET response is aimed at protecting the host from invading bacteria, NETs have also been 
associated with auto-immune and -inflammatory pathology.  Despite NET clearance being highly 
orchestrated, excess and aberrant NET release or clearance may provide a source of inflammatory and 
cytotoxic molecules. Notably, in the autoimmune disease Systemic lupus erythematosus (SLE), 
neutrophil-derived granular proteins associated with NETs, including MPO and PR3, can cause 
autoantibody responses in patients and NET clearance by sera from some patients is impeded [84]. 
This impaired removal of NETs has been attributed to the presence of DNase inhibitors in patients’ 
sera or due to increased levels of anti-NET antibodies or complement factors, which may protect NETs 
from DNAse degradation [85]. Furthermore, delayed removal of NETs may provide a reservoir of PAD4 
hyper-citrullinated proteins, which provides antigens and contributes to disease pathogenesis [86].  In 
the chronic inflammatory disease, rheumatoid arthritis (RA), neutrophils from RA patients have also 
been shown to generate elevated levels of NETs compared with healthy controls [87].  Subsequently, it 
has been demonstrated that the anti-citrullinated protein antibodies (ACPAs) within RA patient serum 
react with the histones in NETs, indicating that they may provide the immunogenic trigger for the 
vicious inflammatory cycle within patients’ joints [88]. Interestingly, P. gingivalis, which is frequently 
found in endodontic infections, possesses its own PAD enzyme [89].  Conceptually, P. gingivalis PAD 
may citrullinate its own or host proteins locally and this may drive inflammation locally within the 
infected root canal network. 
Recent studies in mouse models of lung disease have shown that NETs and their components cause 
significant damage to lung epithelial and endothelial cells. This effect was particularly evident in 
animals with an influenza virus and Streptococcus pneumoniae dual infection and was associated with 
compromised macrophage clearance of NET structures. Data indicated that the viral infection led to  
neutrophil priming, which were subsequently hyper-active in terms of NET release. These dual infected 
animals exhibited increased lung tissue damage, which was associated with exaggerated inflammation 
and damage to the alveolar-capillary barrier as compared with single viral or bacterial infected animals, 
which exhibited increased levels of survival [90,91]. While the immunogenic molecules described above 
could potentially contribute to this pathogenic process, a recent review has highlighted the potentially 
important role of histones in the pathobiology of several diseases [92]. While our preliminary studies 
(unpublished data) and those of others [55] have shown histones to have antibacterial activity, 
including killing of endodontic infection-associated bacteria, histones have also been reported to act as 
damage-associated molecular patterns (DAMPs) when they are released into the extracellular space.  
There are five histone types responsible for the packaging of nuclear DNA and they are categorized 
into two groups: the core histones (H2A, H2B, H3, and H4) and linker histones (H1 and H5) [92].  
Several stress associated mechanisms have been demonstrated to result in their release including 
apoptosis, necrosis and now NETosis. Subsequent cellular detection of extracellular histones by binding 
to receptors, such as TLR-2, -4, -9 and the inflammasome, in a range of cell types triggers activation of 
multiple signaling pathways, e.g. NF-ΚB, MAPK & Caspase-1, in a single or combined manner. This 
cellular activation leads to several processes including pro-inflammatory signaling, induction of cell 
death and platelet activation. Interestingly, high concentrations of serum histones are detected in 
animals or patients with cancer, inflammation, and infection, and inadequate clearance of this cellular 
debris by macrophages may lead to accumulation of these damage or disease markers. Indeed, 
extracellular histones have been considered mediators of several systemic inflammatory diseases and 
sterile inflammation. Potentially, histones now represent a therapeutic target for many infectious and 
inflammatory disorders [92]. 
These published reports relating to the pro-inflammatory and cytotoxic nature of NETs and their 
components have driven us to explore their effects on pulpal cell populations. Our preliminary in vitro 
data are consistent with that seen in other diseases and indicate that single histones, such as H2A or 
combinations of histones, are cytotoxic to human pulp cells and can drive IL-8 release, which 
potentially could perpetuate the chronic inflammatory cycle within the pulpal tissue. Interestingly, the 
exposure of pulp cell cultures to DNA on its own was not able to exert these cellular effects 
(unpublished results). Further work is however required to validate these preliminary findings and 
determine their physiological relevance.  
 
Concluding remarks 
While the exact nature of NETs is still not completely agreed upon, in particular with regards to their 
nuclear or mitochondrial origin [93], the existing data supports NET-DNA release likely representing an 
important evolutionary and conserved antimicrobial mechanism in immunobiology. Indeed, studies of 
plant root-tip pathology have shown that the mucilaginous or ‘slime-like’ matrix encapsulating the 
plant root cap includes significant amounts of extracellular DNA, which inhibits fungal growth [94,95]. 
 It is interesting to postulate that NETs and their components, such as histones, may provide novel 
prognostic markers for pulp pathologies. Indeed, the determination of their levels within diseased 
tissues, such as that of the infected pulp, could be exploited to target application of novel disease 
management strategies. It is also interesting to speculate that the epigenetic state of the histones 
released, including their level of citrullination, may affect their antimicrobial and auto-inflammatory 
properties. Such a concept could underpin the development of novel antibacterial therapeutic 
approaches as it is clear that infecting bacteria, such as P. gingivalis, aim to perpetuate chronic 
inflammation within the host tissue to increase nutrient availability and enable themselves and the 
biofilm to thrive. While some indirect data exist [96] which indicate the presence of NETs in infected 
pulpal tissue and a recent study has highlighted that extracellular DNA can be protected by dentin 
[97], there is now considerable scope for further research to characterize their roles in endodontic 
pathobiology.  
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FIGURE LEGENDS 
Figure 1. Schematic of aspects of the cellular and molecular processes involved in dentin-pulp complex 
immune response to infection. (A) Bacteria colonize and infect the wound, and are subsequently detected 
by tissue resident cells, including immune cells such as dendritic cells (Bi) and mast cells (Bii). Vasoactive 
molecules and chemokines/cytokines are released to generate signals and gradients to enable further 
immune cell populations, such as neutrophils (C), to be recruited from the blood stream. Subsequently 
neutrophils mediate bacterial killing (D) using mechanisms described in Figure 2. The cycle of the 
inflammatory response continues until the infection is cleared. Macrophages will remove bacteria and 
cellular debris and drive resolution of inflammation and subsequently wound regenerative processes will 
be invoked to enable tissue healing. 
 
Figure 2. Neutrophils use both intra- and extra-cellular killing mechanisms to eliminate pathogens. For 
intracellular killing, when neutrophils encounter bacteria, they phagocytose them and encapsulate them in 
phagosomes, prior to eliminating them using ROS or AMPs released from their granules. AMPs can also be 
released into the extracellular environment (degranulation) where they can directly kill bacteria. As 
described in detail within the main text body, NETs can also be released into the extracellular environment 
via a process termed NETosis. The core DNA of NETs is decorated with histones, plus AMPs and enzymes 
that are released from granules. NETs immobilize bacteria preventing their spread, localising them for 
killing with histones and other AMPs, as well as facilitating their phagocytosis. 
 
Figure 3. (A) (i) ROS and (ii) NETs induced at 4 hours stimulated with heat-killed endodontic infection 
associated bacteria, P. gingivalis (MOI 1:100) and F. nucleatum (MOI 1:100), along with the PMA (50nm) 
positive control. Statistical significant differences from negative PBS control are shown with p-values 
*=0.05, **=0.01, ****=0.0001. N=4. (A)(iii) Example fluorescent image of NETs induced by PMA 
stimulation. Nuclei and extruded NETs are stained with Sytox Green. (B) Fluorescent images of (i) control 
(unstimulated) and (ii) F. nucleatum-induced NETs stained with Sytox green. (iii) Fluorescent image 
showing some F. nucleatum bacteria associating with a NET-DNA strand. All techniques for ROS and NET 
analysis imaging were performed as previously reported [65]. Scale bars are shown in micrographs. 
 
 
 
 
Statement of Clinical Relevance (max 75 words) 
Infection of the tooth’s tissues elicits an inflammatory response and until the infection and inflammation 
are resolved then dentin and pulp repair mechanisms are impeded. Neutrophils combat the infection 
within the pulp and release Neutrophil Extracellular Traps (NETs) which encapsulate and kill bacteria. NET 
components however can be pro-inflammatory and cytotoxic. Components of NETs could serve as new 
prognostic markers and provide novel therapeutic targets to aid vital pulp therapy. 
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